DOLOBID Drug Patent Profile
✉ Email this page to a colleague
When do Dolobid patents expire, and when can generic versions of Dolobid launch?
Dolobid is a drug marketed by Merck and is included in one NDA.
The generic ingredient in DOLOBID is diflunisal. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the diflunisal profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dolobid
A generic version of DOLOBID was approved as diflunisal by TEVA on July 31st, 1992.
Summary for DOLOBID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 120 |
| Patent Applications: | 4,068 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DOLOBID at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DOLOBID
US Patents and Regulatory Information for DOLOBID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-001 | Apr 19, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-002 | Apr 19, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DOLOBID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-002 | Apr 19, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-002 | Apr 19, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-001 | Apr 19, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| Merck | DOLOBID | diflunisal | TABLET;ORAL | 018445-001 | Apr 19, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
